openPR Logo
Press release

Drug Repurposing Market Expected to Hit USD 51.80 Bn by 2032, with a CAGR of 4.9% from 2025-2032

Drug Repurposing Market

Drug Repurposing Market

Drug Repurposing Market Overview:

The Drug Repurposing Market was valued at USD 35.33 Bn in 2024 is expected to grow at a CAGR of 4.9% from 2025 to 2032 and reach USD 51.80 Bn by the end of 2032. Drug repurposing, also known as drug repositioning, involves identifying new therapeutic uses for existing drugs. This approach offers several advantages over traditional drug development, including reduced timeframes, lower costs, and improved success rates. By leveraging established safety profiles and manufacturing processes, repurposed drugs can be rapidly deployed to address unmet medical needs. ​

Download a Free Sample Report Today : https://www.maximizemarketresearch.com/request-sample/273130/

Drug Repurposing Market Dynamics

The growth of the drug repurposing market is influenced by several key factors:​

Rising Prevalence of Chronic Diseases: The increasing incidence of chronic and neurodegenerative diseases has heightened the demand for effective treatments, positioning drug repurposing as a viable solution.

Technological Advancements: Innovations in genomics, bioinformatics, and artificial intelligence have enhanced the identification of novel drug-disease relationships, facilitating more efficient repurposing efforts. ​

Regulatory Support: Regulatory agencies are providing frameworks that support expedited approval processes for repurposed drugs, encouraging pharmaceutical companies to invest in this strategy. ​

Drug Repurposing Market Outlook and Future Trends :

The future of the drug repurposing market is shaped by several emerging trends:​

Integration of Artificial Intelligence (AI): AI-driven platforms are being increasingly utilized to predict drug efficacy and identify potential repurposing candidates, streamlining the discovery process.

Collaborative Research Initiatives: Public-private partnerships and cross-industry collaborations are fostering knowledge sharing and resource pooling, accelerating the development of repurposed therapies. ​

Focus on Rare Diseases: There is a growing emphasis on applying drug repurposing strategies to rare and orphan diseases, addressing areas with significant unmet medical needs.

Drug Repurposing Market Key Recent Developments

The drug repurposing market has witnessed notable mergers and acquisitions aimed at enhancing research capabilities and expanding therapeutic portfolios:​

Japan: In February 2025, Bain Capital acquired Mitsubishi Tanabe Pharma for $3.4 billion, aiming to expedite drug development in Japan, particularly for rare diseases. ​

United States: In November 2024, Bayer collaborated with Cytokinetics, acquiring rights in Japan for an experimental heart drug intended to treat hypertrophic cardiomyopathy. ​

Europe: In March 2022, Pfizer acquired Arena Pharmaceuticals for approximately $6.7 billion, expanding its portfolio with development-stage pharmaceuticals in cardiology, dermatology, and gastroenterology

To Gain More Insights into the Market Analysis, Browse Summary of the Research Report :https://www.maximizemarketresearch.com/request-sample/273130/

Drug Repurposing Market Segmentation

by Type Of Approach

Disease-centric
Target-centric
Drug-centric

by Therapeutic Area

Same Therapeutic Area
Different Therapeutic Area

by Drug Molecules

Biologics
Small Molecule

Some of the current players in theDrug Repurposing Market are:

1. Novartis - Switzerland
2. Takeda Pharmaceutical Company - Japan
3. Teva Pharmaceutical Industries - Israel
4. Gilead Sciences - United States
5. Eli Lilly and Company - United States
6. AstraZeneca - United Kingdom/Sweden
7. Pfizer - United States
8. Merck & Co. - United States
9. Bristol-Myers Squibb - United States
10. Johnson & Johnson - United States

Drug Repurposing Market Conclusion :

The drug repurposing market is set for substantial growth, driven by strategic collaborations, technological advancements, and supportive regulatory environments. Continued investment in research and development, along with cross-sector partnerships, is essential to unlock the full potential of drug repurposing and deliver innovative therapies to patients worldwide.

For additional reports on related topics, visit our website:

♦ Global Biopsy Market https://www.maximizemarketresearch.com/market-report/global-biopsy-market/116684/

♦ Medical clothing Market https://www.maximizemarketresearch.com/market-report/medical-clothing-market/147694/

♦ Healthcare Information System Market https://www.maximizemarketresearch.com/market-report/healthcare-information-system-market/124949/

Contact Maximize Market Research:

MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
✆ +91 9607365656
🖂 sales@maximizemarketresearch.com

About Maximize Market Research:

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Repurposing Market Expected to Hit USD 51.80 Bn by 2032, with a CAGR of 4.9% from 2025-2032 here

News-ID: 3953787 • Views:

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Clinical Trials Market Set to Reach USD 88.26 Billion by 2032 with a 6.13% CAGR - Clinical Trials Market Forecast Insights
Clinical Trials Market Set to Reach USD 88.26 Billion by 2032 with a 6.13% CAGR …
According to a new report by Maximize Market Research, the global Clinical Trials Market was valued at USD 54.83 billion in 2024 and is projected to reach USD 88.26 billion by 2032, growing at a CAGR of 6.13%. A major surge in biopharmaceutical R&D and oncology-focused studies is driving the global clinical trials market toward nearly USD 88.26 billion by 2032 at a 6.13% CAGR. ► Get a sample of the
Turbo Trainer Market to Reach USD 421.03 Million by 2032, Growing at a CAGR of 5.16% Driven
Turbo Trainer Market to Reach USD 421.03 Million by 2032, Growing at a CAGR of 5 …
Turbo Trainer Market size was valued at USD 281.52 Mn. in 2024 and the total Turbo Trainer revenue is expected to grow at 5.16% through 2025 to 2032, reaching nearly USD 421.03 Mn. Turbo Trainer Market Overview: The Turbo Trainer Market is witnessing significant growth as fitness enthusiasts increasingly adopt indoor cycling equipment for year-round training. Turbo trainers, which allow users to convert regular bicycles into stationary exercise machines, have become essential
Sodium Acetate Market to Reach USD 354.24 Million by 2032, Growing at a CAGR of 7% Driven
Sodium Acetate Market to Reach USD 354.24 Million by 2032, Growing at a CAGR of …
Sodium Acetate Market size was valued at USD 206.17 Million in 2024, and the total revenue is expected to grow at CAGR of 7 % from 2025 to 2032, reaching nearly USD 354.24 Million. Sodium Acetate Market Overview: The Sodium Acetate Market is experiencing steady growth due to its widespread applications across industries such as food and beverage, pharmaceuticals, textiles, and chemical manufacturing. Sodium acetate, a versatile salt of acetic acid, is
India Tire Market to Reach USD 27.6 Billion by 2033 at 7.6 % CAGR -
India Tire Market to Reach USD 27.6 Billion by 2033 at 7.6 % CAGR - "India Tire …
According to a new report by Maximize Market Research, the India tire market was valued at approximately USD 13.4 billion in 2024 and is expected to climb to USD 27.6 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.6 %. The growth is underpinned by increasing automotive production, growing replacement demand, and rising adoption of radial tyres. ► Get a sample of the report:https://www.maximizemarketresearch.com/request-sample/21022/ ♦ Key Highlights Market size

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase